In multivariate analyses, the models demonstrated limited stability due to the small sample size; however, IGF-1 SDS remained a negative predictor of RHI after adjustment for adiposity indices (BMI SDS and WHR) and key biochemical markers of metabolic syndrome (HDL cholesterol, triglycerides, and insulin). Here, IGF1 is linked to metabolic syndrome.